Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Morten Grunnet

Showing results (61-70 of 132) with videos related to

Pageof 14
Sort By:
Biophysical Journal|September 27, 2002
KCNE5 induces time- and voltage-dependent modulation of the KCNQ1 currentKamilla Angelo, Thomas Jespersen, Morten Grunnet, et al.
Neuropharmacology|August 15, 2006
The acrylamide (S)-1 differentially affects Kv7 (KCNQ) potassium channelsBo Hjorth Bentzen, Nicole Schmitt, Kirstine Calloe, et al.
Pflugers Archiv : European Journal of Physiology|April 27, 2002
Regulation of cloned, Ca2+-activated K+ channels by cell volume changesMorten Grunnet, Nanna MacAulay, Nanna K Jorgensen, et al.
European Journal of Pharmacology|March 22, 2017
Effect of antiarrhythmic drugs on small conductance calcium - activated potassium channelsRafel Simó-Vicens, Daniel R P Sauter, Morten Grunnet, et al.
Pflugers Archiv : European Journal of Physiology|September 3, 2008
Activation of big conductance Ca(2+)-activated K (+) channels (BK) protects the heart against ischemia-reperfusion injuryBo Hjorth Bentzen, Oleg Osadchii, Thomas Jespersen, et al.
European Journal of Pharmacology|April 8, 2015
Biophysical characterization of KV3.1 potassium channel activating compoundsBahar Taskin, Nadia Lybøl von Schoubye, Majid Sheykhzade, et al.
Molecular Pharmacology|July 20, 2007
The small molecule NS11021 is a potent and specific activator of Ca2+-activated big-conductance K+ channelsBo Hjorth Bentzen, Antonio Nardi, Kirstine Calloe, et al.
Obesity (Silver Spring, Md.)|June 21, 2013
Anti-hypertensive treatment preserves appetite suppression while preventing cardiovascular adverse effects of tesofensine in ratsBo Hjorth Bentzen, Morten Grunnet, Lars Hyveled-Nielsen, et al.
Journal of Cardiovascular Pharmacology|July 2, 2009
Pharmacologically induced long QT type 2 can be rescued by activation of IKs with benzodiazepine R-L3 in isolated guinea pig cardiomyocytesJakob Dahl Nissen, Jonas Goldin Diness, Thomas Goldin Diness, et al.
Plos One|June 30, 2015
Late Sodium Current in Human Atrial Cardiomyocytes from Patients in Sinus Rhythm and Atrial FibrillationClaire Poulet, Erich Wettwer, Morten Grunnet, et al.
Pageof 14

Showing results (61-70 of 132) with videos related to

Sort By:
Pageof 14
Biophysical Journal|September 27, 2002
KCNE5 induces time- and voltage-dependent modulation of the KCNQ1 currentKamilla Angelo, Thomas Jespersen, Morten Grunnet, et al.
Neuropharmacology|August 15, 2006
The acrylamide (S)-1 differentially affects Kv7 (KCNQ) potassium channelsBo Hjorth Bentzen, Nicole Schmitt, Kirstine Calloe, et al.
Pflugers Archiv : European Journal of Physiology|April 27, 2002
Regulation of cloned, Ca2+-activated K+ channels by cell volume changesMorten Grunnet, Nanna MacAulay, Nanna K Jorgensen, et al.
European Journal of Pharmacology|March 22, 2017
Effect of antiarrhythmic drugs on small conductance calcium - activated potassium channelsRafel Simó-Vicens, Daniel R P Sauter, Morten Grunnet, et al.
Pflugers Archiv : European Journal of Physiology|September 3, 2008
Activation of big conductance Ca(2+)-activated K (+) channels (BK) protects the heart against ischemia-reperfusion injuryBo Hjorth Bentzen, Oleg Osadchii, Thomas Jespersen, et al.
European Journal of Pharmacology|April 8, 2015
Biophysical characterization of KV3.1 potassium channel activating compoundsBahar Taskin, Nadia Lybøl von Schoubye, Majid Sheykhzade, et al.
Molecular Pharmacology|July 20, 2007
The small molecule NS11021 is a potent and specific activator of Ca2+-activated big-conductance K+ channelsBo Hjorth Bentzen, Antonio Nardi, Kirstine Calloe, et al.
Obesity (Silver Spring, Md.)|June 21, 2013
Anti-hypertensive treatment preserves appetite suppression while preventing cardiovascular adverse effects of tesofensine in ratsBo Hjorth Bentzen, Morten Grunnet, Lars Hyveled-Nielsen, et al.
Journal of Cardiovascular Pharmacology|July 2, 2009
Pharmacologically induced long QT type 2 can be rescued by activation of IKs with benzodiazepine R-L3 in isolated guinea pig cardiomyocytesJakob Dahl Nissen, Jonas Goldin Diness, Thomas Goldin Diness, et al.
Plos One|June 30, 2015
Late Sodium Current in Human Atrial Cardiomyocytes from Patients in Sinus Rhythm and Atrial FibrillationClaire Poulet, Erich Wettwer, Morten Grunnet, et al.
Pageof 14